EFDID: 38072EFD: View Filing

Issuer: FLUOROPHARMA MEDICAL, INC. (0001402785) - D

Accession: 0001140361-11-030822 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001402785
  • Entity Name:
    FLUOROPHARMA MEDICAL, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEVADA
  • Year of Inc:
    Within 5 years (2007)
  • Address:
    500 Boylston Street, Suite 1600
    Boston, MA 02116
  • Persons:
    Related Persons 4
    Johan (Thijs) M. Spoor
    Executive OfficerDirector
    David R. Elmaleh
    Executive OfficerDirector
    Walter Witshkin
    Director
    Peter S. Conti
    Director
EDGAR: Offering Information
  • Accession Date:
    06/01/2011
  • First Sale Date:
    05/16/2011
  • Offering Amount:
    $6,000,000
  • Amount Sold:
    $3,667,442
  • Amount Remaining:
    $2,332,558
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Burnham Hill Partners, LLC 148000 None None CA, NY, TX
Monarch Capital Group, LLC 47815 None None CT, MN, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
FLUOROPHARMA MEDICAL, INC./s/ Johan M. (Thijs) SpoorJohan M. (Thijs) SpoorChief Executive Officer2011-06-01